
Doug Drysdale
DOUG DRYSDALE was the global head of M&A at Actavis, closing 15 transactions totaling approximately $1bn, doubling the size of the business during his tenure. Then, as founding CEO of Alvogen, he took company from inception to over $450mm of sales in 36 countries in five years. His career spans 28-years where he has spearheaded several hundred pharmaceutical and biotech transactions, a CNS development company, has brought low cost medicines to U.S. consumers, and has served as CEO of both private and public companies.